Literature DB >> 9486602

Radiation treatment of glottic squamous cell carcinoma, stage I and II: analysis of factors affecting prognosis.

G Franchin1, E Minatel, C Gobitti, R Talamini, G Sartor, G Caruso, G Grando, D Politi, M Gigante, G Toffoli, M G Trovò, L Barzan.   

Abstract

PURPOSE: At least in some European Countries, there is still considerable controversy regarding the choice between surgery and radiotherapy for the treatment of patients with early laryngeal-glottic carcinoma. METHODS AND MATERIALS: Two hundred and forty-six patients with laryngeal-glottic neoplasms, Stage I-II, were treated with radical radiotherapy. Before radiotherapy the patients were evaluated to determine the surgical procedure of choice. Either 66-68.4 Gy (33-38 fractions) or 63-65 Gy (28-29 fractions) of radiation therapy (RT) were administered. The overall disease free survival was determined for each subgroup of patients. Univariate and multivariate analyses were performed to determine significant prognostic variables.
RESULTS: Five- and 10-year overall survival rates were 83 and 72%, respectively. At a median follow-up of 6 years 204 patients are alive and disease free. No patient developed distant metastases. One patient died of a large local recurrence, 38 patients died of causes unrelated to their tumor, and 3 patients were lost to follow-up. The multivariate analysis confirmed that performance status (PS), macroscopic presentation of the lesion, and persistence of dysphonia after radiotherapy are significant prognostic factors.
CONCLUSIONS: According to the multivariate analysis, the patients with PS > 80 and with exophytic lesions are eligible for radical RT. The surgical procedure proposed for each patient was not found to be an independent prognostic factor.

Entities:  

Mesh:

Year:  1998        PMID: 9486602     DOI: 10.1016/s0360-3016(97)00768-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

Review 1.  Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review.

Authors:  Federico Maria Gioacchini; Michele Tulli; Shaniko Kaleci; Stefano Bondi; Mario Bussi; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-19       Impact factor: 2.503

2.  Retrospective analysis: concurrent chemoradiotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer.

Authors:  Yoshiyuki Itoh; Nobukazu Fuwa
Journal:  Radiat Med       Date:  2006-05

3.  BCCIP as a prognostic marker for radiotherapy of laryngeal cancer.

Authors:  Amar Rewari; Huimei Lu; Rahul Parikh; Qifeng Yang; Zhiyuan Shen; Bruce G Haffty
Journal:  Radiother Oncol       Date:  2008-11-27       Impact factor: 6.280

4.  Predictive factors for local control of early glottic squamous cell carcinomas after definitive radiotherapy.

Authors:  Mitsuru Okubo; Tomohiro Itonaga; Tatsuhiko Saito; Sachika Shiraishi; Ryuji Mikami; Akira Sakurada; Shinji Sugahara; Jinho Park; Koichi Tokuuye; Kazuhiro Saito
Journal:  Mol Clin Oncol       Date:  2020-03-30

5.  Organ preservation and oncological outcomes in early laryngeal cancer: a propensity score-based study.

Authors:  Genival Barbosa de Carvalho; Hugo Fontan Kohler; Julia Bette Homem de Mello; Renan Bezerra Lira; Antonio Cássio de Assis Pellizzon; José Guilherme Vartanian; Luiz Paulo Kowalski
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-08       Impact factor: 2.124

Review 6.  Organ preservation strategies in the treatment of laryngeal cancer.

Authors:  George E Laramore; Marc D Coltrera
Journal:  Curr Treat Options Oncol       Date:  2003-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.